ATE215380T1 - Verwendung von interleukin-12 fuer die verhinderung von transplantat gegen empfaengerkrankheit - Google Patents
Verwendung von interleukin-12 fuer die verhinderung von transplantat gegen empfaengerkrankheitInfo
- Publication number
- ATE215380T1 ATE215380T1 AT95908628T AT95908628T ATE215380T1 AT E215380 T1 ATE215380 T1 AT E215380T1 AT 95908628 T AT95908628 T AT 95908628T AT 95908628 T AT95908628 T AT 95908628T AT E215380 T1 ATE215380 T1 AT E215380T1
- Authority
- AT
- Austria
- Prior art keywords
- interleukin
- prevention
- against recipient
- transplant against
- recipient disease
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5434—IL-12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/208—IL-12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Transplantation (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/186,529 US5573764A (en) | 1994-01-21 | 1994-01-21 | Use of interleukin-12 to prevent graft versus host disease |
PCT/US1995/000879 WO1995019786A1 (en) | 1994-01-21 | 1995-01-20 | Use of interleukin-12 to prevent graft versus host disease |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE215380T1 true ATE215380T1 (de) | 2002-04-15 |
Family
ID=22685309
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95908628T ATE215380T1 (de) | 1994-01-21 | 1995-01-20 | Verwendung von interleukin-12 fuer die verhinderung von transplantat gegen empfaengerkrankheit |
Country Status (14)
Country | Link |
---|---|
US (2) | US5573764A (de) |
EP (1) | EP0739212B1 (de) |
JP (1) | JP3825043B2 (de) |
AT (1) | ATE215380T1 (de) |
AU (1) | AU698410B2 (de) |
CA (1) | CA2181568C (de) |
DE (1) | DE69526206T2 (de) |
DK (1) | DK0739212T3 (de) |
ES (1) | ES2179096T3 (de) |
IL (1) | IL112373A (de) |
PT (1) | PT739212E (de) |
TW (1) | TW349021B (de) |
WO (1) | WO1995019786A1 (de) |
ZA (1) | ZA95463B (de) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5573764A (en) * | 1994-01-21 | 1996-11-12 | Genetics Institute, Inc. | Use of interleukin-12 to prevent graft versus host disease |
US5674483A (en) * | 1995-01-31 | 1997-10-07 | National Jewish Medical And Research Center | Treatment for diseases involving inflammation |
WO1996024369A1 (en) * | 1995-02-06 | 1996-08-15 | Genetics Institute, Inc. | Formulations for il-12 |
WO1997016203A1 (en) * | 1995-11-01 | 1997-05-09 | Genetics Institute, Inc. | Methods for administration of il-12 |
CA2268365A1 (en) * | 1996-10-18 | 1998-04-30 | Jeff Nordstrom | Il-12 gene expression and delivery systems and uses |
AU4908197A (en) * | 1996-10-18 | 1998-05-15 | Valentis, Inc. | Gene expression and delivery systems and uses |
AU6150498A (en) * | 1997-02-07 | 1998-08-26 | Wistar Institute, The | Methods and compositions for the inhibition of interleukin-12 production |
DE69825395T2 (de) * | 1997-05-16 | 2005-01-13 | Toray Industries, Inc. | Medikament, behandlungsmethode, prophylaktikum und prophylaxe gegen immunologische erkrankungen von hunden und katzen |
EP1516630A3 (de) * | 1997-10-31 | 2006-05-03 | Wyeth | Verwendung von anti-il-12 Antikörpern bei Transplantationsabstossungen |
US6080399A (en) * | 1998-04-23 | 2000-06-27 | Arch Development Corporation | Vaccine adjuvants for immunotherapy of melanoma |
US7115712B1 (en) * | 1999-12-02 | 2006-10-03 | Maxygen, Inc. | Cytokine polypeptides |
US7638496B2 (en) | 2000-02-15 | 2009-12-29 | Valeant Pharmaceuticals North America | Nucleoside analogs with carboxamidine modified monocyclic base |
WO2003004625A1 (en) * | 2001-07-02 | 2003-01-16 | The Government Of The United States Of America As Represented By The Secretary Of Health And Human Services | Methods of generating human cd4+ th2 cells and uses thereof |
WO2003020904A2 (en) * | 2001-08-31 | 2003-03-13 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Methods of generating human cd4+ th1 cells |
US7718196B2 (en) * | 2001-07-02 | 2010-05-18 | The United States Of America, As Represented By The Department Of Health And Human Services | Rapamycin-resistant T cells and therapeutic uses thereof |
US20040258661A1 (en) * | 2001-10-31 | 2004-12-23 | Daniel Fowler | Generation of use of tc1 and tc2 cells |
DE10248141B4 (de) * | 2002-10-11 | 2007-04-19 | Universitätsklinikum Hamburg-Eppendorf | Nukleinsäuren und deren Verwendung für die Gentherapie |
US7939058B2 (en) * | 2003-07-03 | 2011-05-10 | University Of Southern California | Uses of IL-12 in hematopoiesis |
MX2010003720A (es) * | 2007-10-08 | 2010-10-20 | Intrexon Corp | Celulas dendriticas creadas por ingenieria genetica y usos para el tratamiento de cancer. |
US20100272863A1 (en) * | 2009-04-24 | 2010-10-28 | Griebel Jonathan M | Soft shaped tortillas |
JP6267510B2 (ja) | 2010-05-18 | 2018-01-24 | ニューメディシンズ,インコーポレーテッド | 造血を増強するためのil−12製剤 |
WO2012174056A1 (en) | 2011-06-13 | 2012-12-20 | Neumedicines, Inc. | Mitigation of cutaneous injury with il-12 |
WO2013016634A1 (en) | 2011-07-27 | 2013-01-31 | Neumedicines, Inc. | Use of il-12 to generate endogenous erythropoietin |
US11951157B2 (en) | 2011-10-11 | 2024-04-09 | Universitat Zurich | Methods of treating malignant tumour with IL-12 and anti-PD-1 antibody |
JP6489353B2 (ja) * | 2011-10-11 | 2019-03-27 | ウニヴェルズィテート チューリッヒ | 腫瘍療法のためのil−12とt細胞阻害分子遮断薬とを含む医薬組成物 |
CA2862290A1 (en) | 2012-01-18 | 2013-10-17 | Neumedicines, Inc. | Il-12 for radiation protection and radiation-induced toxicity mitigation |
WO2013158959A1 (en) * | 2012-04-19 | 2013-10-24 | Tarix Pharmaceuticals Ltd. | Compositions and methods for treatment of graft-versus-host disease |
IL297186A (en) * | 2020-04-17 | 2022-12-01 | Univ Leland Stanford Junior | Transgenic il-12 and il-23 polypeptides and their uses |
WO2022081776A1 (en) * | 2020-10-13 | 2022-04-21 | Kriya Therapeutics, Inc. | Viral vector constructs for delivery of nucleic acids encoding cytokines and uses thereof for treating cancer |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA931489B (en) * | 1992-03-04 | 1993-10-28 | Schering Corp | Use of interleuken-10 to suppress graft-vs-host disease |
DE4315127A1 (de) * | 1993-05-07 | 1994-11-10 | Behringwerke Ag | Arzneimittel enthaltend die Untereinheit p40 von Interleukin-12 |
US5573764A (en) * | 1994-01-21 | 1996-11-12 | Genetics Institute, Inc. | Use of interleukin-12 to prevent graft versus host disease |
-
1994
- 1994-01-21 US US08/186,529 patent/US5573764A/en not_active Expired - Lifetime
-
1995
- 1995-01-16 TW TW084100334A patent/TW349021B/zh active
- 1995-01-18 IL IL112373A patent/IL112373A/en not_active IP Right Cessation
- 1995-01-20 ES ES95908628T patent/ES2179096T3/es not_active Expired - Lifetime
- 1995-01-20 WO PCT/US1995/000879 patent/WO1995019786A1/en active IP Right Grant
- 1995-01-20 AT AT95908628T patent/ATE215380T1/de active
- 1995-01-20 EP EP95908628A patent/EP0739212B1/de not_active Expired - Lifetime
- 1995-01-20 JP JP51970895A patent/JP3825043B2/ja not_active Expired - Lifetime
- 1995-01-20 AU AU16875/95A patent/AU698410B2/en not_active Ceased
- 1995-01-20 DE DE69526206T patent/DE69526206T2/de not_active Expired - Lifetime
- 1995-01-20 CA CA002181568A patent/CA2181568C/en not_active Expired - Lifetime
- 1995-01-20 PT PT95908628T patent/PT739212E/pt unknown
- 1995-01-20 ZA ZA95463A patent/ZA95463B/xx unknown
- 1995-01-20 DK DK95908628T patent/DK0739212T3/da active
-
1996
- 1996-04-30 US US08/640,386 patent/US5756085A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP3825043B2 (ja) | 2006-09-20 |
DE69526206D1 (de) | 2002-05-08 |
CA2181568A1 (en) | 1995-07-27 |
ZA95463B (en) | 1995-09-27 |
US5573764A (en) | 1996-11-12 |
ES2179096T3 (es) | 2003-01-16 |
DE69526206T2 (de) | 2002-11-21 |
DK0739212T3 (da) | 2002-06-03 |
AU698410B2 (en) | 1998-10-29 |
EP0739212B1 (de) | 2002-04-03 |
IL112373A0 (en) | 1995-03-30 |
US5756085A (en) | 1998-05-26 |
PT739212E (pt) | 2002-08-30 |
WO1995019786A1 (en) | 1995-07-27 |
EP0739212A1 (de) | 1996-10-30 |
CA2181568C (en) | 2007-09-18 |
AU1687595A (en) | 1995-08-08 |
JPH09508371A (ja) | 1997-08-26 |
TW349021B (en) | 1999-01-01 |
IL112373A (en) | 2006-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE215380T1 (de) | Verwendung von interleukin-12 fuer die verhinderung von transplantat gegen empfaengerkrankheit | |
PL323825A1 (en) | Peptidyloheterocycli compounds useful in treating diorders associated with thrombosin | |
NO924619D0 (no) | (+)-alfa-(2,3-dimetoksyfenyl)-1-(2-(4-fluorfenyl)ethyl)-4-piperidinmetanol | |
TR199701212T1 (xx) | �drar� tutamama halinin tedavisi i�in alfa IL- agonistlerinin kullan�lmas�. | |
DK0755249T3 (da) | Anvendelse af Maillard-reaktionsinhibitor til behandling af amyloidose-baseret sygdom | |
TW200505434A (en) | Therapeutic treatment | |
DE69420967D1 (de) | Lösung zur verwendung gegen den pilzbefall von nägeln | |
NO20006357L (no) | Anvendelse av optisk ren (+)-norcisaprid ved behandling av apné, bulimi og andre sykdommer | |
ATE159424T1 (de) | Verwendung von hydroxylierte carbonsäure zur behandlung von nägeln | |
PL324750A1 (en) | Expressive construct p16 and posiibility of using it in treating carcinomas | |
NZ504419A (en) | The use of carvedilol for treating amyloid diseases such as Alzheimer's | |
ZA975288B (en) | The use of TCET in the prophylaxis and treatment of allergies. | |
UA37199C2 (uk) | Алкіламінокетони | |
DE59004277D1 (de) | Copolymerisat sowie dessen Verwendung. | |
WO1996005845A3 (en) | Treatment of disease and conditions associated with macrophage infiltration in particular stroke and myocardial infarction | |
DE69626816D1 (de) | Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren | |
ATE243036T1 (de) | Levobupivacain und dessen verwendung als anästhetikum bei schwangeren frauen | |
NO20006358L (no) | Anvendelse av optisk ren (-)-norcisaprid ved behandling av apné, bulimi og andre sykdommer | |
AP2000001950A0 (en) | Paroxetine maleate. | |
GB9626472D0 (en) | New use of comt inhibitors | |
NO902620D0 (no) | Drivstoff og brenselbehandling. | |
ES2173180T3 (es) | Derivados del mercaptoacetilamida hipocolesterolemicos, antiateroescleroticos e hipotrigliceridemicos. | |
SE9403861D0 (sv) | Novel medicinal use | |
ATE294590T1 (de) | Verwendung von interleukin-11 zur behandlung von hämoragischem schock | |
TR200103662T2 (tr) | Yeni kalpainler ve bunların kullanılması |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEFA | Change of the company name |